Lumacang, Ajijul Radzhata .
HRN: 26-19-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/08/2024
AMPICILLIN 250MG (VIAL)
11/08/2024
11/15/2024
IV
250
Q6
URTI
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaURTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes